GGrantIndex
Sort

261,768 grants matching gene therapy

Adoptive Cell Transfer Immunotherapy of Cancer

$4,725,194
Steven Rosenberg · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA

Gene therapy of cancer

$4,725,194
Steven Rosenberg · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA

Cell and Gene Therapy for HIV Cure

$4,714,991
Keith R Jerome · Fred Hutchinson Cancer Research Center · UM1 · FY2018 · AI

Cell and Gene Therapy for HIV Cure

$4,714,991
Keith R Jerome · Fred Hutchinson Cancer Research Center · UM1 · FY2017 · AI

Cell and Gene Therapy for HIV Cure

$4,714,991
Keith R Jerome · Fred Hutchinson Cancer Research Center · UM1 · FY2016 · AI

Human Biochemical Genetics

$4,714,987
William Gahl · National Human Genome Research Institute · ZIA · FY2018 · HG

Procurement and Characterization of Postmortem Brain Tissue

$4,711,045
Stefano Marenco · National Institute Of Mental Health · ZIC · FY2023 · MH

GENETIC SUSCEPTIBILITY TO CANCER IN MULTIETHNIC COHORTS

$4,704,903
University Of Southern California · R01 · FY2004 · CA

T1D:Investigating the Gut Microbiome, Urinary Proteome and Metabolome

$4,700,934
Rembert Pieper · J. Craig Venter Institute, Inc. · DP3 · FY2011 · DK

Cancer Immunotherapy Trials Network Central Operations and Statistical Center

$4,695,150
Martin Cheever · Fred Hutchinson Cancer Research Center · UM1 · FY2017 · CA

Human Biochemical Genetics

$4,692,970
William Gahl · National Human Genome Research Institute · ZIA · FY2017 · HG

Clinical Research and Protocol Support Services

$4,692,368
William O'Donnell · National Eye Institute · ZID · FY2011 · EY

Building on the success of the adoptive immunotherapy of cancer

$4,687,435
Nicholas P Restifo · Basic Sciences · Z01 · FY2007 · CA

JACKSON HEART STUDY

$4,685,764
Herman Taylor · University Of Mississippi Med Ctr · N01 · FY2011 · HL

Correction of Neurological Disease via Allele Specific Excision of Pathogenic Repeats

$4,683,536
Jennifer A Doudna · University Of California Berkeley · U19 · FY2023 · NS

I4C 2.0: Immunotherapy for Cure

$4,677,761
Dan H. Barouch · Beth Israel Deaconess Medical Center · UM1 · FY2022 · AI

I4C 2.0: Immunotherapy for Cure

$4,669,992
Dan H. Barouch · Beth Israel Deaconess Medical Center · UM1 · FY2023 · AI

DCTD Screening Technologies

$4,669,431
David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2014 · CA

Proteomic and Genetic Approaches Defining Apolipoprotein E4 Neuropathologic Mechanisms

$4,669,193
Robert W. Mahley · J. David Gladstone Institutes · RF1 · FY2019 · AG

Enterprise for Research and Advocacy to Stop and Eradicate HIV (ERASE-HIV)

$4,667,081
Mirko Paiardini · Emory University · UM1 · FY2024 · AI

Enterprise for Research and Advocacy to Stop and Eradicate HIV (ERASE-HIV)

$4,663,729
Mirko Paiardini · Emory University · UM1 · FY2025 · AI

Human Biochemical Genetics

$4,658,970
William Gahl · National Human Genome Research Institute · ZIA · FY2016 · HG

Childhood Cancer Survivor Study

$4,654,448
Leslie L Robison · St. Jude Children'S Research Hospital · U24 · FY2007 · CA

I4C 2.0: Immunotherapy for Cure

$4,653,643
Dan H. Barouch · Beth Israel Deaconess Medical Center · UM1 · FY2025 · AI

Ethnic/Racial Variation in Intracerebral Hemorrhage (ERICH)

$4,641,809
Daniel Woo · University Of Cincinnati · U01 · FY2011 · NS